Evidence map›Paper›PMID 28038319›Full record

ArticleNeoplasia (New York, N.Y.)2017

Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.

Hua Zhou, Maricel G Kann, Emily K Mallory, Ying-Hua Yang, Amr Bugshan, Nada O Binmadi, John R Basile

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Neoplasia (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hua ZhouDepartment of Oncology and Diagnostic Sciences, University of Maryland Dental School, 650 W. Baltimore Street, 7-North, Baltimore, MD 21201, USA.
Maricel G KannDept of Biological Sciences, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA.
Emily K MalloryBiomedical Informatics Training Program, Stanford University, 1265 Welch Road, Stanford, CA 94305, USA.
Ying-Hua YangDepartment of Oncology and Diagnostic Sciences, University of Maryland Dental School, 650 W. Baltimore Street, 7-North, Baltimore, MD 21201, USA.
Amr BugshanDepartment of Oncology and Diagnostic Sciences, University of Maryland Dental School, 650 W. Baltimore Street, 7-North, Baltimore, MD 21201, USA.
Nada O BinmadiDepartment of Oncology and Diagnostic Sciences, University of Maryland Dental School, 650 W. Baltimore Street, 7-North, Baltimore, MD 21201, USA; Department of Oral Basic & Clinical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
John R BasileDepartment of Oncology and Diagnostic Sciences, University of Maryland Dental School, 650 W. Baltimore Street, 7-North, Baltimore, MD 21201, USA; Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD 21201, USA. Electronic address: jbasile@umaryland.edu.
University of Maryland, Baltimore · USStanford University · USUniversity of Maryland, Baltimore County · US

Funding

The Role of Semaphorin 4D and Plexin-B1 in Tumor-Induced Angiogenesis.R01CA133162 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI BASILE, JOHN R. · 2009 to 2013
$1.5M
Protein domains as molecular units to unravel functional pathways of cancer genesK22CA143148 · NCI · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI KANN, MARICEL G. · 2009 to 2011
$490k
NCI NIH HHS K22 CA143148NCI NIH HHS R01 CA133162
6 · The paper itself

Abstract

The semaphorins and the plexins are a family of large, cysteine-rich proteins originally identified as regulators of axon growth and lymphocyte activation that are now known to provide motility and positional information for a number of cell and tissue types. For example, our group and others have shown that some malignancies over express Semaphorin 4D (S4D), which acts through its receptor Plexin-B1 (PB1) on endothelial cells to attract blood vessels from the surrounding stroma for the purpose of supporting tumor growth. While plexins are the known functional receptors for the semaphorins, there is evidence that transmembrane semaphorins may transmit a signal themselves through their short cytoplasmic tail, a phenomenon known as 'reverse signaling.' We used computational methods based upon correlated evolution of sequences of interacting proteins, mutational analysis and in vitro and in vivo measurements of tumor aggressiveness to show that when bound to PB1, transmembrane S4D associates with the Rac GTPase exchange factor T lymphoma invasion and metastasis (Tiam) 1, which activates Rac and promotes proliferation, invasion and metastasis in oral squamous cell carcinoma (OSCC) cells. These results suggest that not only can S4D production by tumor cells affect the microenvironment, but engagement of this semaphorin at the cell surface activates a reverse signaling mechanism that influences tumor aggressiveness in OSCC.

Indexed as

AnimalsAntigens, CDBiopsyCarcinoma, Squamous CellCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalDNA-Binding ProteinsGene ExpressionGuanine Nucleotide Exchange FactorsHumansMiceMouth NeoplasmsNeoplasm MetastasisNuclear ProteinsAntigens, CDCD100 antigenDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsNuclear ProteinsPBRM1 protein, humanrac GTP-Binding ProteinsSemaphorinsTIAM1 protein, humanT-Lymphoma Invasion and Metastasis-inducing Protein 1Transcription Factors

Identifiers

PMID28038319
PMCPMC5198113
OpenAlexW2563986400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.